Mark Luksic
Email: *********@********.***
Address: *** ***** *** *****
City: Malvern
State: PA
Zip: 19355
Country: USA
Phone: 610-***-****
Skill Level: Management
Salary Range: $140,000
Primary Skills/Experience:
See Resume
Educational Background:
See Resume
Job History / Details:
Mark J. Luksic
800 Trout Run Drive, Malvern, PA 19355 610-***-**** (m) *********@********.***
Executive Summary
Strategic Planning and Program Management Leader (PMP Certified, MBA - Finance) with
demonstrated proficiencies in planning and execution as a team leader in sales, information technology,
finance operations, strategic planning and portfolio management seeking a leadership role that helps
senior management to drive business alignment between company goals and organizational capabilities
Key Strengths
Getting things done, Leading teams, Strategy execution, Performance management, Financial Analysis,
Developing individuals, Aligning organizations, Relationship building, Cross disciplinary skill set
Key Corporate Experiences
Pharmaceutical R&D - Portfolio Management, Performance Management & R&D Operations
Corporate Finance - CFO Executive Support Staff, Merger and Acquisition Planning & Operations and Analysis
Information Technology - Strategic Planning, IT Program Management Office & Vendor Management
Telecommunications Industry - Account Management, Strategic Account Planning & Sales Leadership
President and Majority Equity Owner - M Luksic, LLC d/b/a DeMarco Landscaping, 2012-present
Owner of a $2mm, well-established, full-service landscape design and maintenance business that serves residential
and commercial customers throughout the metropolitan Philadelphia area. Responsibilities include field operations,
financial management, design review, estimating, RFP response, customer service and personnel management.
Director/Team Leader - Portfolio Management & Analytics - Wyeth & Pfizer Inc, 2008-June 2011
Led a team of business analysts to evaluate asset valuation criteria that highlights 240 drug programs' medical
differentiation in the areas of safety, efficacy, tolerability and commercial potential across the entire development
portfolio; created visualization graphics to report on differentiation changes and trends
Partnered with portfolio management analytical teams to create a common analytical platform that enables key
stakeholders in finance, business development and operations to use a standard analytical model to evaluate, analyze
and model the valuation of drug candidates across all discovery platforms and clinical development phases
Collaborated with IT, R&D lines and finance teams to assess resource modeling practices and to establish standards
for development teams to better forecast and measure the resources needed to deliver the portfolio
Hosted panel interviews with HR and our leadership team to assess staff capabilities and to recruit new talent; results
included 4 new hires and 4 internal promotions in 2010; established a rotational program for junior staff
Wyeth R&D - Partnered with business development and finance managers to plan, design and implement an
improved due diligence process that better enables drug development and commercial branding teams to assess and
prioritize alliance and licensing opportunities in support of the Wyeth executive leadership team
Wyeth Office of Integration Planning - Program Leader responsible for the prioritization of integration analysis and
data submissions to align organizational capabilities with Pfizer's Real Estate, Facilities and Corporate Services and
to identify $100MM in cost savings synergies in support of the Pfizer-Wyeth merger (Oct, 2009)
Wyeth R&D - Portfolio Management development initiative - led a team of business analysts and IS systems
engineers to plan, design, test and implement a software application that enabled Wyeth's Global Clinical Team to
forecast and measure operating costs and FTE resources in order to execute over $700MM of annual studies in
support of drug development plans; this team received the R&D President's Team of the Year Award in 2008
Associate Director - R&D Portfolio & Project Management, Pfizer Inc, New London, CT, 2006-2008
Built a dashboard of portfolio metrics and external benchmarks to compare Pfizer's R&D survival and cycle time
performance to its pharmaceutical industry peers and set annual performance goals for development teams
Developed a seven year historical performance summary that enabled the R&D executive team to better understand
how variances in cycle time and attrition affect goal delivery and portfolio valuation
Built a productivity index model that ranks the R&D investment and development pipelines of Pfizer and its peers
including the anticipated commercial value of all Phase 2-Registration compounds in development
Conducted benchmarking analyses to highlight Pfizer's performance trends in early clinical development and to
uncover novel ways to improve the application of biomarkers as a means of predicting clinical trial outcomes
Mark J. Luksic
800 Trout Run Drive, Malvern, PA 19355 610-***-**** (m) *********@********.***
Manager, Operations, Planning & Analysis, Corporate Finance, Pfizer Inc, New York, NY, 2003-2006
Facilitated discussions with Pfizer's CFO and finance division vice presidents to create the quarterly forecast and
audit processes for Pfizer's $4B corporate restructuring program in 2005; developed a global forecasting tool that
enabled teams to forecast and measure their restructuring program savings and costs versus targets
Led a CFO-selected team to evaluate Pfizer's budget and assessment policies, recommend improvements and created
a corporate-wide process that enabled business units to eliminate over $2B in non-value added accounting
transactions per year that also enabled Pfizer Inc to maintain its favorable global tax positions
Managed the Pfizer Contingent Share Award program to provide Pfizer's Board of Directors with monthly updates on
Pfizer's Earnings per Share and Total Shareholder Return performance vs. its peer group; worked with Investor
Relations to file the performance summary in 10-K and 10-Q filings with the SEC
Analyzed and consolidated strategic operating plans and financial schedules for Pfizer's 2005 Budget ($52 billion in
revenue) for 12 operating divisions in support of the CEO & his executive leadership team
Pharmacia acquisition - Developed quarterly performance summaries for executive management to highlight
variances between forecasts and results for $6.5B in merger-related costs & $4.5B in savings synergies
Worked with marketing teams to create NPV and cash flow analyses of over-the-counter pharmaceutical and direct-
to-consumer products representing ~$350MM in new revenue to Pfizer Consumer Healthcare
Led a team of strategic planning directors and finance leaders to redesign the annual Strategic Management Process
that elevated the content and utility of operating plans for executive management to set corporate level goals and
priorities; this effort also reduced the time and effort required to develop Pfizer's long range plan
Developed executive-level presentations for the CFO to present to the Board of Directors and business unit leaders in
order to evaluate strategic opportunities, forecast quarterly earnings and review Pfizer's performance
Project Manager, Corporate Information Technology, Pfizer Inc, New York, NY, 1999-2003
Led a team of business analysts and software designers to translate business needs into software code, test systems
and implement a scalable, web-based portal for 85,000 employees to access Pfizer's business policy and code-of-
conduct training education modules in support of Pfizer's Legal Compliance division
Led a team of network and systems analysts to migrate 15,000 IT end users from Pfizer's data center, wide area
network and messaging systems in order to prepare for the Adams and Schick company divestitures in 2003
Project-managed a global, cross-business unit team to test client software, train helpdesk analysts, develop helpdesk
procedures and to deploy a remote access client software application for 45,000 global employees
Worked with Division VPs and Pfizer's CIO to create a global program management office that enables all global IT
project teams to consistently and effectively plan, manage, execute and support 80 annual IT projects worth $235MM
in capital expenditures in order to deliver quality IT services and applications
Negotiated $12MM of annual global service contracts for Pfizer's telecommunications equipment maintenance
agreements, enterprise end-user software licenses, IT research services and professional consulting services
National Account Manager, AT&T, Parsippany, NJ, 1993-1999
Proposed, developed and negotiated a three-year, $8MM outsourcing service contract and implemented a 29-site,
managed global data network for Witco Corporation, (now part of Crompton & Witco)
Proposed, negotiated and closed a three-year, $5MM new service contract to provide a telecommuting service
application for 4,000 remote sales professionals for Hoffmann-La Roche
Led a team of four sales professionals to execute performance objectives in revenue growth, including $7MM in new
sales revenue from 1996 to 1998, 157% quota attainment, technical service resolution, and career development;
Awarded the Regional Vice President's Gold Club Award for sales achievement in 1995, 1996 and 1998
Education
MBA Finance & International Business, Seton Hall University, South Orange, NJ, 2003
BA Advertising & Public Relations, University of South Carolina, Columbia, SC, 1992
PMP Certified (Project Management Professional)
References will be furnished upon request